Star Combo Pharma Limited (ASX:S66)

Revenue by Segment

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016
Star Combo Business	25.83M	23.36M	20.75M	16.21M	12.54M
Star Combo Business Growth	10.57%	12.55%	28.05%	29.22%	-6.50%
Austoyou Retail	1.99M	2.66M	3.95M	6.67M	14.18M
Austoyou Retail Growth	-25.39%	-32.60%	-40.85%	-52.95%	-44.21%
Total	27.81M	26.02M	24.70M	22.88M	26.72M
Total Growth	6.89%	5.34%	7.95%	-14.38%	-31.18%

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016
Australia	26.37M	24.81M	20.48M	16.67M	16.73M
Australia Growth	6.26%	21.13%	22.89%	-0.39%	-15.68%
China	1.45M	1.21M	4.22M	6.21M	9.99M
China Growth	19.78%	-71.38%	-32.12%	-37.83%	-47.39%
Total	27.81M	26.02M	24.70M	22.88M	26.72M
Total Growth	6.89%	5.34%	7.95%	-14.38%	-31.18%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 16, 2026

Data Sources Report a data error